Cycle Venture Partners

Investor type Venture Capital
Founders Alan Kersey


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 2
Average round size
The average size of a deal this fund participated in
Portfolio companies 2
Lead investments 0
Key employees 1
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Life Science
  • Health Care

Among the various public portfolio startups of the fund, we may underline Cybrexa Therapeutics Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Therapeutics.

The typical case for the fund is to invest in rounds with 3 participants. Despite the Cycle Venture Partners, startups are often financed by HighCape Partners, Connecticut Innovations. The meaningful sponsors for the fund in investment in the same round are HighCape Partners, Connecticut Innovations.

The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2019.

Besides them, we counted 1 critical employee of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Cycle Venture Partners:
Typical Co-investors
Cycle Venture Partners is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Cycle Venture Partners:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
8i Ventures India, Maharashtra, Mumbai
Chinese Media China, Guangdong, Jiangxi
Guanda Ruitou Beijing, Beijing, China
Huizenga Capital Management Illinois, Oak Brook, United States
Impres Health -
Langfang Wuxian Beijing, China, Tongzhou
MDC Ventures New York, New York, United States
Milla Investment AS Norway, Oslo
New Life Ventures -
NewGaoQiao E-Business China, Fujian, Hunan
Novastar Ventures Kenya, Nairobi, Nairobi Area
Owl Ventures California, San Francisco, United States
Rabo Frontier Ventures Netherlands, Utrecht, Utrecht
RS Investments California, San Francisco, United States
Salem Partners California, Los Angeles, United States
Salt Lake Life Science Angels Salt Lake City, United States, Utah
The Libra Foundation California, San Francisco, United States
Theta Capital -
Zhiyou Fangcun China, Guangdong, Shenzhen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
Life Science
$4M08 Apr 2021 Rocky Hill, Connecticut, United States

Cybrexa Therapeutics

$13M21 Jun 2019 New Haven, Connecticut, United States
Lumeda Announces $4.3M in Series A

– Lumeda, a medical technology company, announced the closing of its $4.3M Series A financing.
– The round was led by Connecticut Innovations, with participation from Cycle Venture Partners and brings the total amount raised to date to $5.3m.
– Both firms, along with angel investors, participated in the company’s Seed funding round in early 2020.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cycle Venture Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: